Lopinavir Main Page

Medical Advocates
Lopinavir/Ritonavir (Kaletra/Aluvia)

Main Page

New and Noteworthy
Journal Papers/Abstracts/ Commentaries
Conference Abstracts and Posters
Pediatric Indications
Perinatal Data
Therapeutic Monitoring
Product Information
Protease Inhibitors: General Data
Database of ARV Drug Interactions

Main New/Newsworthy Drugs Home

This web page is best viewed by using INTERNET EXPLORER
Last Update: April 13, 2018
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

April 2018

FULL-TEXT ARTICLE
High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial
Pasquau J, Hidalgo-Tenorio C, Montes ML, et alPLoS One. 2018 Apr 12;13(4):e0195068.
Raltegravir versus lopinavir/ritonavir for treatment of HIV-infected late-presenting pregnant women.
Brites C, Nóbrega I, Luz E, et al HIV Clin Trials. 2018 Apr 9:1

March 2018

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).
Meynard JL, Moinot L, Landman R, Morand-Joubert L, et al J Antimicrob Chemother. 2018 Mar 23.

Main New/Newsworthy Drugs Home

Lopinavir Main Page